These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 37240744)

  • 1. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs.
    Kumari L; Choudhari Y; Patel P; Gupta GD; Singh D; Rosenholm JM; Bansal KK; Kurmi BD
    Life (Basel); 2023 Apr; 13(5):. PubMed ID: 37240744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs.
    Khan KU; Minhas MU; Badshah SF; Suhail M; Ahmad A; Ijaz S
    Life Sci; 2022 Feb; 291():120301. PubMed ID: 34999114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.
    Bhalani DV; Nutan B; Kumar A; Singh Chandel AK
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs.
    Mahmood T; Sarfraz RM; Ismail A; Ali M; Khan AR
    Assay Drug Dev Technol; 2023; 21(2):65-79. PubMed ID: 36917562
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
    Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
    Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs.
    Saini M; Bhatt S; Dureja H; Solanki N
    Recent Pat Nanotechnol; 2023 Nov; ():. PubMed ID: 38037907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs.
    Tran P; Park JS
    Int J Pharm; 2021 Dec; 610():121247. PubMed ID: 34740762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - A comprehensive review.
    Padrela L; Rodrigues MA; Duarte A; Dias AMA; Braga MEM; de Sousa HC
    Adv Drug Deliv Rev; 2018 Jun; 131():22-78. PubMed ID: 30026127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules.
    Choudhary S; Gupta L; Rani S; Dave K; Gupta U
    Front Pharmacol; 2017; 8():261. PubMed ID: 28559844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Overview on Recent Patents and Technologies on Solid Dispersion.
    Kaushik R; Budhwar V; Kaushik D
    Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
    Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
    Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to address low drug solubility in discovery and development.
    Williams HD; Trevaskis NL; Charman SA; Shanker RM; Charman WN; Pouton CW; Porter CJ
    Pharmacol Rev; 2013 Jan; 65(1):315-499. PubMed ID: 23383426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery.
    Baumgartner A; Planinšek O
    Eur J Pharm Sci; 2021 Dec; 167():106015. PubMed ID: 34547382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.
    Paudwal G; Rawat N; Gupta R; Baldi A; Singh G; Gupta PN
    Curr Pharm Des; 2019; 25(13):1524-1535. PubMed ID: 31258070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Hydrotropic Solubilization Techniques for Enhancing the Bioavailability of Poorly Soluble Drugs.
    Sharma U; Saroha K
    Int J Toxicol; 2024; 43(1):63-71. PubMed ID: 37999970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs.
    Nyamba I; Sombié CB; Yabré M; Zimé-Diawara H; Yaméogo J; Ouédraogo S; Lechanteur A; Semdé R; Evrard B
    Eur J Pharm Biopharm; 2024 Nov; 204():114513. PubMed ID: 39313163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update.
    Jermain SV; Brough C; Williams RO
    Int J Pharm; 2018 Jan; 535(1-2):379-392. PubMed ID: 29128423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process.
    Park J; Cho W; Cha KH; Ahn J; Han K; Hwang SJ
    Int J Pharm; 2013 Jan; 441(1-2):50-5. PubMed ID: 23262425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosizing of drugs: Effect on dissolution rate.
    Dizaj SM; Vazifehasl Zh; Salatin S; Adibkia Kh; Javadzadeh Y
    Res Pharm Sci; 2015; 10(2):95-108. PubMed ID: 26487886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.